|4Jan 6, 4:59 PM ET

Brown Spencer D. 4

4 · PDS Biotechnology Corp · Filed Jan 6, 2023

Insider Transaction Report

Form 4
Period: 2023-01-05
Brown Spencer D.
Senior VP, General Counsel
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-01-05+20,40020,400 total
    Exercise: $11.61Exp: 2033-01-05Common Stock (20,400 underlying)
Footnotes (1)
  • [F1]This option, representing a right to purchase a total of 20,400 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027.

Documents

1 file
  • 4
    form4.xmlPrimary